Individuals with IREB2-associated neurodegeneration reported to date have had global developmental delay with neurodegeneration, dystonia, seizures, anemia associated with altered iron metabolism, and mitochondrial dysfunction. One child died with the disorder died at age 10 years from progressive neurological disease.
IREB2